编辑丨王多鱼 排版丨水成文 海南医科大学基础医学院招聘教职人员 招聘岗位 ：教职岗位和博士后职位 研究领域 ：包括但不限于癌症、热带病原体与免疫生物学、心血管与代谢疾病、神经科学、干细胞与再生 医学、基础医学及相关生物医学领域。 一、教职岗位 资格要求 ：申请人须拥有博士学位或医学博士/哲学博士学位，并已完成数年的博士后培训或具备相关工业 研究经验。候选人应展现出强大的独立研究能力，具备解决生物医学研究前沿和/或关键核心技术领域重大 原创科学问题的实绩。申请人应已确立明确且独特的研究方向，并取得显著的学术成就。 1、资深研究员 （ Senior PI） 候选人应专注于前沿科学问题和/或核心关键技术，已建立具有国际竞争力和独特性的研究项目，并展现出 卓越的学术成就。资深研究员一经任命，将获得：独立的实验室空间；硕士和博士研究生指导名额；用于 研究助理和技术人员的专项经费。 2、特聘研究员 （ Junior PI ） 候选人应聚焦于原创性科学问题和/或关键核心技术，学术成就应与世界顶尖大学或一流研究机构的优秀博 士后相当。 研究启动资金 ——资深研究员，600 万至 800 万元人民币；特聘研究员，100 万元人 ...

Financial Performance - In 2024, the company achieved a revenue of 64,502.19 million yuan, representing a year-on-year growth of 18.65% [1] - The net profit attributable to shareholders was 12,383.25 million yuan [1] - In Q1 2025, the company reported a revenue of 18,649.04 million yuan, with a year-on-year increase of 27.73% [1] - The net profit for Q1 2025 was 4,057.85 million yuan, reflecting a growth of 32.30% [1] Business Strategy - The company focuses on biomedicine and cell immunotherapy, emphasizing a market-oriented and customer-centric approach [1] - A comprehensive optimization of internal management has been implemented to enhance competitiveness and profitability [1] CGT (Cell and Gene Therapy) Development - The company offers a full range of solutions from drug target discovery to commercial production for cell and gene therapy clients [2] - It has developed a series of recombinant proteins and unique antibodies for CAR-T product development, including a specific antibody targeting CD19 [2] - The company has successfully developed nearly 50 GMP-grade products for CGT applications, ensuring high-quality standards [3] ADC (Antibody-Drug Conjugates) Development - ADCs combine targeted antibodies with potent chemotherapy drugs, minimizing harm to normal cells while maximizing therapeutic effects [4] - The company provides a range of products and services for ADC development, including target proteins and linker enzymes [5] Neuroscience Research - The company focuses on providing high-quality recombinant proteins and neurotrophic factors for brain science research [7] - It has developed products targeting neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as diagnostic proteins [7]